Research map: Genomic alterations and transcriptional phenotypes in circulating free DNA and matched metastatic tumor

Back to the article

Papers in this map

  1. An integrated encyclopedia of DNA elements in the human genome · Ian Dunham · 2012 · 19875 citations · Cited by this paper
  2. Advancing therapeutics in small-cell lung cancer · Anish Thomas · 2025 · 32 citations · Cites this paper
  3. Cumulative cgMLST provides increased discrimination of nested phylogenetic groups · Armen Ovsepian · 2026 · 1 citation · Related
  4. Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities · Sven Heinz · 2010 · 15002 citations · Cited by this paper
  5. Nanotechnology-Assisted Molecular Profiling: Emerging Advances in Circulating Tumor DNA Detection · Jiayi Kang · 2026 · 4 citations · Cites this paper
  6. Transcriptome signatures for the identification of bevacizumab responders in ovarian cancer · 2026 · Related
  7. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions · Daehwan Kim · 2013 · 13867 citations · Cited by this paper
  8. CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized level · Mukulika Bose · 2025 · 2 citations · Cites this paper
  9. Circulating tumor DNA precision oncology enables effective and sensitive molecular diagnostics and actionable target detection in pediatric solid tumors - the INFORM experience · 2026 · Related
  10. Complex heatmaps reveal patterns and correlations in multidimensional genomic data · Zuguang Gu · 2016 · 11337 citations · Cited by this paper
  11. Multifeature sequencing-based liquid biopsy for cancer diagnosis and monitoring · Mariano A. Molina · 2026 · 1 citation · Cites this paper
  12. Integrative stratification of response to immunotherapy using host and microbial signatures in patients with advanced non-small cell lung cancer · 2026 · Related
  13. Maftools: efficient and comprehensive analysis of somatic variants in cancer · Anand Mayakonda · 2018 · 5596 citations · Cited by this paper
  14. Open chromatin-guided interpretable machine learning reveals cancer-specific chromatin features in cell-free DNA · Sakuntha Gunarathna · 2025 · 1 citation · Cites this paper
  15. Cell type-specific contextualisation of the human phenome: towards the systematic treatment of all rare diseases · 2026 · Related
  16. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples · Kristian Cibulskis · 2013 · 5466 citations · Cited by this paper
  17. Exploring the mechanism of action of abemaciclib in breast cancer through circulating chromatin fragments · Mamoru Takada · 2026 · 1 citation · Cites this paper
  18. Long-read transcriptome sequencing and Drosophila-based functional validation reveal novel gene fusions in fusion panel-negative gliomas · 2026 · Related
  19. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies · Chetan Bettegowda · 2014 · 5213 citations · Cited by this paper
  20. Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung Cancer · Damien Vasseur · 2026 · 1 citation · Cites this paper
  21. Comprehensive genomic characterization of extraintestinal pathogenic Escherichia coli isolated from neonates: multiple center insights into virulence, resistance, and transmission dynamics · 2026 · Related
  22. The repertoire of mutational signatures in human cancer · Ludmil B. Alexandrov · 2020 · 3858 citations · Cited by this paper
  23. Molecular Mechanisms and Clinical Significance of Chromosomal Instability in Solid Tumors: A Focus on Lung Cancer · 娅 包 · 2026 · Cites this paper
  24. Infiltrating monocyte-derived macrophages does not survive long term in stroke brain despite their dominance in the acute ischemic core and myeloid derived IGF-1 play dichotomous roles in stroke recovery · 2026 · Related
  25. PARP inhibitors: Synthetic lethality in the clinic · Christopher J. Lord · 2017 · 2989 citations · Cited by this paper
  26. Reframing small cell lung cancer: therapeutic lessons from hematologic malignancies · Kanak Parmar · 2026 · Cites this paper
  27. Application of genetic features and serial ctDNA in estimating response and prognosis of immunotherapy-based total neoadjuvant therapy (iTNT) for microsatellite stable locally advanced rectal cancer: data from TORCH trial · 2026 · Related
  28. Detection and localization of surgically resectable cancers with a multi-analyte blood test · Joshua David Cohen · 2018 · 2878 citations · Cited by this paper
  29. Lineage infidelity in small-cell lung cancer: driving subtype transitions and acquired therapeutic vulnerabilities · Isaac Johnson Ajeh · 2026 · Cites this paper
  30. Comprehensive genomic profiles of small cell lung cancer · Julie George · 2015 · 2447 citations · Cited by this paper
  31. Exploring copy number alterations (CNAs) to gain new insight into SCLC heterogeneity · Natalia Galant · 2026 · Cites this paper
  32. Strelka2: fast and accurate calling of germline and somatic variants · Sangtae Kim · 2018 · 1826 citations · Cited by this paper
  33. Small-cell lung cancer · Charles M. Rudin · 2021 · 1631 citations · Cited by this paper
  34. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data · Charles M. Rudin · 2019 · 1339 citations · Cited by this paper
  35. Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer · Melinda L. Telli · 2016 · 1198 citations · Cited by this paper
  36. rtracklayer: an R package for interfacing with genome browsers · Michael F. Lawrence · 2009 · 1107 citations · Cited by this paper
  37. Resistance to checkpoint blockade therapy through inactivation of antigen presentation · Moshe Sade-Feldman · 2017 · 1035 citations · Cited by this paper
  38. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities · Carl Michael Gay · 2021 · 990 citations · Cited by this paper
  39. Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer · Scott N. Gettinger · 2017 · 792 citations · Cited by this paper

Source: OpenAlex (CC0)